exRNAdisease

Entry Detail

---



General Information

Database ID: exR0730400 RNA Name: hsa-miR-432-5p RNA Type: miRNA Chromosome: chr14 Starnd: + Coordinate: Start Site(bp): 100884496 End Site(bp): 100884518 External Links: hsa-miR-432-5p

Disease Information

Disease Name: Prostate Cancer Disease Category: Cancers MeSH ID: D011471 Type: Neoplasms/Digestive System Neoplasms Alias: Prostatic Neoplasms//Prostate Neoplasms//Neoplasms, Prostate//Neoplasm, Prostate//Prostate Neoplasm//Neoplasms, Prostatic//Neoplasm, Prostatic//Prostatic Neoplasm//Prostate Cancer//Cancer, Prostate//Cancers, Prostate//Prostate Cancers//Cancer of the Prostate//Prostatic Cancer//Cancer, Prostatic//Cancers, Prostatic//Prostatic Cancers//Cancer of Prostate

Expression Detail

GEO ID: GSE54010 Description: miRNA expression profiles in the 19 candidate urines (prostate cancer, CaP, patients and non-cancer subjects with benign prostatic hyperplasia, BPH) Experimental Design: Cancer vs Control Case Disease Type: Prostate Cancer Case Disease SubType: Advanced Prostate Cancer Case Sample: Localized Prostate Cancer Control Sample: Benign Prostatic Hyperplasia Number of Case: 7 Number of Control: 5 Number of Samples: 12

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand ABL1 chr9 130713016 130887675 + ANXA2 chr15 60347134 60402883 - ATP5MC3 chr2 175176258 175184607 - BLCAP chr20 37492472 37527931 - CA12 chr15 63321378 63381846 - CALM1 chr14 90396502 90408268 + CELSR2 chr1 109249539 109275751 + CHTF8 chr16 69118010 69132578 - DNAJC13 chr3 132417502 132539032 + EPB41 chr1 28887091 29120046 + FADS2 chr11 61792980 61867354 + FN1 chr2 215360440 215436073 - GGA3 chr17 75236599 75262363 - GNAI2 chr3 50226292 50259362 + HMBOX1 chr8 28890395 29064764 + IGF1R chr15 98648539 98964530 + IPO9 chr1 201829149 201884291 + KDM3B chr5 138352685 138437028 + MFHAS1 chr8 8783354 8893630 - NAPEPLD chr7 103099776 103149560 - PHC3 chr3 170086732 170181749 - PRELID3B chr20 59033145 59042809 - PTCD3 chr2 86106223 86142157 + RASA1 chr5 87267883 87391931 + SETD7 chr4 139495941 139606699 - STAMBP chr2 73828916 73873659 + TMEM63A chr1 225845536 225882380 - TOB2 chr22 41433494 41446801 - ZBTB34 chr9 126860665 126885878 + ZNF12 chr7 6688433 6706947 - miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0001454 chr4 154524454 154533552 + hsa_circ_0001349 chr3 152132729 152150709 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC009133.5 chr16 29808679 29812227 + AC016876.2 chr17 7581964 7584086 - AC068768.1 chr12 123262060 123262402 + AC239868.1 chr1 149861271 149862504 + KCNQ1OT1 chr11 2608328 2699994 - LINC00649 chr21 33915534 33977691 + NEAT1 chr11 65422774 65445540 + PCBP2-OT1 chr12 53464468 53465057 + SNHG16 chr17 76557764 76565348 + XIST chrX 73820649 73852723 - ZFAS1 chr20 49278178 49299600 + Display:

Experiment Detail

GEO ID: GSE54010 Sample Source: Urine Source Fraction: Urine Platform: GPL15159 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 1183 Sample treatment protocol: NA RNA Extract protocol: Total RNA was extracted using RecoverAllTM Total Nucleic Acid Isolation kit (Life Technologies, Carlsbad, CA). RNA library preparation protocol: 400 ng of total RNA was labeled with cyanine 3-pCp using the Agilent miRNA Complete Labeling kit and hybridized to the array according to the manufacturer's protocol.

Reference

PMID: NA Title: NA Author: NA Journal: NA Description: NA